Market Cap ₹89626 Cr.
Stock P/E 49.5
P/B 12.4
Current Price ₹505.7
Book Value ₹ 40.8
Face Value 1
52W High ₹672
Dividend Yield 1.09%
52W Low ₹ 489
Dabur India Limited is a FMCG company. Its segments comprises Consumer care commercial enterprise, Food enterprise, Retail business and Other segments. Its Consumer care enterprise section consists of home care, personal care, and health care. Its Food commercial enterprise section includes juices, liquids, and culinary. Its Retail commercial enterprise segment consists of retail stores. Its Other segments are Guar gum, pharma and others. Its product categories consist of hair care, oral care, fitness care, skin care, home care and ingredients. Its FMCG portfolio consists of 8 manufacturers, consisting of Dabur Chyawanprash, Dabur Honey, Dabur PudinHara, Dabur Lal Tail and Dabur Honitus in the healthcare area; Dabur Amla and Dabur Red Paste within the personal care category; and Real within the food and Beverage's category. In addition, Vatika is an global logo. Its products are Real Juices, Dabur Red Paste, Odonil, Odomos, Dabur Hommade Tasty Masala, Rheumatil Oil, Dabur Badam Oil, Odopic, Oxy bleach and Hajmola.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 4870 | 5431 | 5340 | 5291 | 5592 | 6273 | 6310 | 7185 | 8180 | 8684 | 9136 | |
Other Income | 110 | 138 | 194 | 280 | 283 | 275 | 277 | 277 | 342 | 392 | 418 | |
Total Income | 4980 | 5569 | 5534 | 5570 | 5876 | 6548 | 6587 | 7461 | 8521 | 9077 | 9553 | |
Total Expenditure | 4045 | 4493 | 4243 | 4181 | 4366 | 4909 | 4932 | 5629 | 6449 | 6988 | 7301 | |
Operating Profit | 935 | 1076 | 1291 | 1389 | 1510 | 1639 | 1655 | 1833 | 2072 | 2089 | 2252 | |
Interest | 19 | 10 | 10 | 21 | 22 | 30 | 19 | 9 | 19 | 46 | 81 | |
Depreciation | 53 | 66 | 71 | 74 | 100 | 106 | 127 | 140 | 157 | 184 | 205 | |
Exceptional Income / Expenses | -1 | -24 | 0 | 0 | -15 | 0 | -100 | 0 | 0 | -30 | 0 | |
Profit Before Tax | 861 | 977 | 1209 | 1294 | 1373 | 1503 | 1408 | 1683 | 1896 | 1829 | 1967 | |
Provision for Tax | 189 | 214 | 272 | 296 | 301 | 239 | 238 | 301 | 463 | 455 | 457 | |
Profit After Tax | 672 | 763 | 937 | 998 | 1072 | 1264 | 1170 | 1382 | 1433 | 1373 | 1509 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 672 | 763 | 937 | 998 | 1072 | 1264 | 1170 | 1382 | 1433 | 1373 | 1509 | |
Adjusted Earnings Per Share | 3.9 | 4.3 | 5.3 | 5.7 | 6.1 | 7.2 | 6.6 | 7.8 | 8.1 | 7.8 | 8.5 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 5% | 8% | 8% | 6% |
Operating Profit CAGR | 8% | 7% | 7% | 9% |
PAT CAGR | 10% | 3% | 4% | 8% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -5% | -3% | 2% | 8% |
ROE Average | 23% | 24% | 26% | 30% |
ROCE Average | 28% | 30% | 31% | 36% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 1902 | 2336 | 3094 | 3658 | 4227 | 3969 | 4574 | 5391 | 5864 | 6287 | 6915 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 1 | 201 | 201 | 26 | 25 | 0 | 249 | 249 | 499 |
Other Non-Current Liabilities | 356 | 366 | 399 | 150 | 150 | 66 | 38 | 59 | 171 | 185 | 227 |
Total Current Liabilities | 1440 | 1647 | 1591 | 1209 | 1234 | 1518 | 1442 | 2036 | 2308 | 2632 | 2891 |
Total Liabilities | 3697 | 4349 | 5085 | 5217 | 5813 | 5579 | 6078 | 7487 | 8592 | 9352 | 10533 |
Fixed Assets | 654 | 683 | 639 | 942 | 980 | 987 | 1086 | 1157 | 1353 | 1617 | 1834 |
Other Non-Current Assets | 859 | 1686 | 2229 | 2489 | 2874 | 2467 | 1727 | 3499 | 4605 | 5505 | 5267 |
Total Current Assets | 2185 | 1980 | 2217 | 1786 | 1959 | 2124 | 3265 | 2830 | 2634 | 2231 | 3432 |
Total Assets | 3697 | 4349 | 5085 | 5217 | 5813 | 5579 | 6078 | 7487 | 8592 | 9352 | 10533 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 67 | 146 | 13 | 24 | -1 | 58 | -20 | -22 | 7 | 10 | 15 |
Cash Flow from Operating Activities | 712 | 839 | 960 | 927 | 816 | 1124 | 1155 | 1704 | 1320 | 1562 | 1653 |
Cash Flow from Investing Activities | -101 | -616 | -498 | -682 | -262 | 417 | -332 | -1121 | -683 | -619 | -738 |
Cash Flow from Financing Activities | -535 | -337 | -455 | -274 | -496 | -1619 | -826 | -555 | -635 | -940 | -922 |
Net Cash Inflow / Outflow | 76 | -114 | 8 | -29 | 58 | -79 | -3 | 28 | 2 | 4 | -6 |
Closing Cash & Cash Equivalent | 146 | 36 | 24 | -1 | 58 | -20 | -22 | 7 | 10 | 15 | 11 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 3.85 | 4.34 | 5.33 | 5.67 | 6.09 | 7.16 | 6.62 | 7.82 | 8.11 | 7.75 | 8.52 |
CEPS(Rs) | 4.16 | 4.72 | 5.73 | 6.09 | 6.65 | 7.76 | 7.34 | 8.61 | 8.99 | 8.79 | 9.67 |
DPS(Rs) | 1.75 | 2 | 2.25 | 2.25 | 7.5 | 2.75 | 3 | 4.75 | 5.2 | 5.2 | 5.5 |
Book NAV/Share(Rs) | 10.4 | 13.01 | 17.07 | 20.26 | 23.47 | 22.05 | 25.36 | 29.8 | 32.33 | 35.15 | 38.48 |
Core EBITDA Margin(%) | 16.75 | 17.05 | 20.22 | 20.66 | 20.48 | 20.43 | 20.3 | 20.09 | 19.51 | 17.98 | 18.25 |
EBIT Margin(%) | 17.88 | 17.92 | 22.49 | 24.5 | 23.3 | 22.96 | 21.03 | 21.86 | 21.59 | 19.86 | 20.37 |
Pre Tax Margin(%) | 17.48 | 17.74 | 22.3 | 24.1 | 22.93 | 22.51 | 20.75 | 21.74 | 21.38 | 19.37 | 19.56 |
PAT Margin (%) | 13.64 | 13.85 | 17.28 | 18.59 | 17.9 | 18.93 | 17.24 | 17.85 | 16.15 | 14.55 | 15.01 |
Cash Profit Margin (%) | 14.72 | 15.05 | 18.6 | 19.96 | 19.57 | 20.52 | 19.11 | 19.66 | 17.93 | 16.5 | 17.05 |
ROA(%) | 19.61 | 18.96 | 19.87 | 19.38 | 19.44 | 22.2 | 20.08 | 20.37 | 17.82 | 15.31 | 15.18 |
ROE(%) | 40.68 | 37.22 | 35.45 | 30.38 | 27.83 | 31.5 | 27.95 | 28.35 | 26.09 | 23 | 23.13 |
ROCE(%) | 46.97 | 44.72 | 43.2 | 36.94 | 33 | 34.88 | 31.72 | 32.97 | 32.14 | 28.37 | 28.33 |
Receivable days | 21.43 | 21.94 | 25.56 | 25.62 | 19.95 | 20.57 | 21.81 | 15.58 | 15.14 | 19.64 | 23.24 |
Inventory Days | 39.21 | 36.75 | 39.25 | 41.29 | 39.74 | 39.29 | 41.46 | 45.33 | 48.39 | 47.6 | 43.09 |
Payable days | 104.17 | 104.44 | 122.03 | 146.33 | 155.13 | 141.88 | 150.66 | 158.88 | 163.66 | 164.55 | 184.06 |
PER(x) | 46.59 | 61.14 | 46.76 | 48.9 | 53.73 | 57.15 | 67.98 | 69.15 | 66.2 | 70.33 | 61.42 |
Price/Book(x) | 17.27 | 20.41 | 14.59 | 13.68 | 13.93 | 18.56 | 17.76 | 18.14 | 16.6 | 15.51 | 13.59 |
Dividend Yield(%) | 0.97 | 0.75 | 0.9 | 0.81 | 2.29 | 0.67 | 0.67 | 0.88 | 0.97 | 0.95 | 1.05 |
EV/Net Sales(x) | 6.38 | 8.59 | 8.21 | 9.28 | 10.34 | 11.55 | 12.55 | 13.21 | 11.64 | 11.18 | 10.22 |
EV/Core EBITDA(x) | 33.23 | 43.32 | 33.97 | 35.33 | 38.29 | 44.19 | 47.86 | 51.78 | 45.96 | 46.49 | 41.43 |
Net Sales Growth(%) | 11.97 | 11.52 | -1.68 | -0.92 | 5.7 | 12.18 | 0.58 | 13.87 | 13.85 | 6.17 | 5.2 |
EBIT Growth(%) | 14.66 | 12.01 | 23.64 | 7.87 | 6.04 | 9.9 | -6.88 | 18.54 | 13.15 | -2.09 | 9.22 |
PAT Growth(%) | 13.73 | 13.46 | 22.91 | 6.52 | 7.38 | 17.93 | -7.43 | 18.07 | 3.69 | -4.16 | 9.9 |
EPS Growth(%) | 13.67 | 12.64 | 22.72 | 6.37 | 7.38 | 17.61 | -7.47 | 18.06 | 3.66 | -4.38 | 9.89 |
Debt/Equity(x) | 0.02 | 0.06 | 0.03 | 0.08 | 0.07 | 0.08 | 0.03 | 0.03 | 0.09 | 0.09 | 0.1 |
Current Ratio(x) | 1.52 | 1.2 | 1.39 | 1.48 | 1.59 | 1.4 | 2.26 | 1.39 | 1.14 | 0.85 | 1.19 |
Quick Ratio(x) | 1.13 | 0.87 | 1.01 | 0.98 | 1.02 | 0.92 | 1.7 | 0.84 | 0.61 | 0.38 | 0.79 |
Interest Cover(x) | 45.51 | 99.74 | 118.87 | 62.03 | 63.73 | 51.45 | 74.09 | 185.17 | 102.57 | 40.44 | 25.24 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 67.24 | 67.24 | 66.24 | 66.24 | 66.23 | 66.23 | 66.24 | 66.25 | 66.24 | 66.25 |
FII | 20.23 | 20.24 | 20.47 | 19.73 | 19.39 | 18.38 | 16.49 | 15.83 | 14.98 | 15.04 |
DII | 4.04 | 6.62 | 7.55 | 8.38 | 8.81 | 9.85 | 11.72 | 12.52 | 13.52 | 13.63 |
Public | 8.5 | 5.9 | 5.75 | 5.66 | 5.57 | 5.53 | 5.54 | 5.4 | 5.26 | 5.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 119.13 | 119.13 | 117.35 | 117.35 | 117.36 | 117.37 | 117.39 | 117.4 | 117.4 | 117.41 |
FII | 35.84 | 35.86 | 36.27 | 34.96 | 34.36 | 32.56 | 29.22 | 28.04 | 26.55 | 26.66 |
DII | 7.15 | 11.73 | 13.37 | 14.84 | 15.61 | 17.46 | 20.77 | 22.18 | 23.96 | 24.15 |
Public | 15.05 | 10.45 | 10.19 | 10.03 | 9.87 | 9.81 | 9.82 | 9.58 | 9.32 | 9 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 177.17 | 177.18 | 177.18 | 177.18 | 177.2 | 177.2 | 177.2 | 177.2 | 177.23 | 177.23 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About